| Subcribe via RSS




Latest Leukemia News

February 22nd, 2008 Posted in Cancer Research Notes

news imageImatinib Effective Over Long Term in Refractory Leukemia
Imatinib mesylate (Gleevec®) therapy shows lasting safety and efficacy in chronic-phase chronic myeloid leukemia patients in whom interferon-alpha treatment has failed.

Taken from LeukemiaLinks, your monthly source of leukemia news, research updates, clinical trials and events sponsored by The Leukemia & Lymphoma Society (LLS). For even more information, regularly visit their Patient Services and Disease Information Web sections.


Related Posts & Pages

Comments are closed.